These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30212968)

  • 1. Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.
    Tan P; Xie N; Liao H; Zou L; Xu H; Yang L; Liu L; Wei Q
    Medicine (Baltimore); 2018 Sep; 97(37):e12300. PubMed ID: 30212968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.
    Luo Y; Feng B; Wei D; Han Y; Li M; Zhao J; Lin Y; Hou Z; Jiang Y
    Sci Rep; 2020 Oct; 10(1):17674. PubMed ID: 33077839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
    Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
    Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy.
    Fletcher SA; Pallauf M; Watts EK; Lombardo KA; Campbell JA; Rezaee ME; Rouprêt M; Boorjian SA; Potretzke AM; Roshandel MR; Ploussard G; Djaladat H; Ghoreifi A; Mari A; Campi R; Khene ZE; Raman JD; Kikuchi E; Rink M; Abdollah F; Boormans JL; Fujita K; D'Andrea D; Soria F; Breda A; Hoffman-Censits J; McConkey DJ; Shariat SF; Pradere B; Singla N
    Eur Urol Oncol; 2024 Oct; 7(5):1061-1068. PubMed ID: 38262800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
    Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
    BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
    Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
    World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
    Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
    Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?
    Yeh HC; Chien TM; Wu WJ; Li CC; Li WM; Ke HL; Chou YH; Wang CJ; Huang SP; Li CF; Liang PI; Huang CN
    Urol Oncol; 2016 Aug; 34(8):337.e1-9. PubMed ID: 27133951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interethnic differences in the impact of body mass index on upper tract urothelial carcinoma following radical nephroureterectomy.
    Yeh HC; Li CC; Chien TM; Li CY; Cheng YC; Woldu SL; Robyak H; Huang CN; Ke HL; Li WM; Lee HY; Yeh BW; Yang SF; Tu HP; Sagalowsky AI; Raman JD; Singla N; Margulis V; Lotan Y; Hsieh JT; Wu WJ
    World J Urol; 2021 Feb; 39(2):491-500. PubMed ID: 32318857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
    BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
    Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
    BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the preoperative controlling nutritional status score as an independent predictor in a large Chinese cohort of patients with upper tract urothelial carcinoma.
    Xu H; Tan P; Jin X; Ai J; Lin T; Lei H; Yang L; Wei Q
    Cancer Med; 2018 Dec; 7(12):6112-6123. PubMed ID: 30485712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.